ATS 2019 Virtual Final Program

3:45 Regional Rates of Primary Care Visits, ICU Admission, and Mechanical Ventilation/ A.J. Admon, H.C. Prescott, T.S. Valley, T.J. Iwashyna, C.R. Cooke, Ann Arbor, MI, p.A5576 4:00 Effect of Severe Trauma on Work and Earnings/ A. Garland, S.-H. Jeon, M. Rotermann, M. Stepner, R. Fransoo, C. Sanmartin, H. Wunsch, D.C. Scales, T.J. Iwashyna, B. Haas, Winnipeg, Canada, p.A5577 CLINICAL MINI SYMPOSIUM C96 COPD AND PLEURAL DISEASE 2:15 p.m. - 4:15 p.m. KBHCCD Ballroom C Three-Four (Level 2) Chairing: D.J. Feller-Kopman, MD, Baltimore, MD S. Bose, MD, MPH, Baltimore, MD Oral Presentations 2:15 Lung Microbiota Associations with Clinical Features of COPD in the SPIROMICS Cohort/ Y.J. Huang, K. Opron, J. Erb-Downward, L. Begley, N.E. Alexis, I. Barjaktarevic, R.G. Barr, E.R. Bleecker, R.P. Bowler, S. Christenson, A.P. Comellas, C.B. Cooper, D. Couper, C.M. Doerschuk, M.T. Dransfield, M.K. Han, N.N. Hansel, A.T. Hastie, E.A. Hoffman with E.A. Hoffman, R.J. Kaner, J.A. Krishnan, W.K. O'Neal, R. Paine, S.P. Peters, J.M. Wells, P. Woodruff, F.J. Martinez, M. Bates, C.M. Freeman, J.L. Curtis, G.B. Huffnagle, Ann Arbor, MI, p.A5578 2:30 Alpha-1 Antitrypsin Deficiency PI*Z and PI*S Allele Frequency in a Direct-to-Consumer Genetic Database/ H. Nhan, J. Zhan, J. Perry, J.K. Stoller, E. Kim, Mountain View, CA, p.A5579 2:45 Pulmonary Arterial Pruning and Progression of Percent Emphysema on CT: The COPDGene Study/ C.P. Aaron, S.Y. Ash, C. Come, A.A. Diaz, J.E. Hokanson, G.L. Kinney, P. Nardelli, F.N. Rahaghi, K. Young, R.G. Barr, G.R. Washko, R. San Jose Estepar, Boston, MA, p.A5580 3:00 First Line Simple Aspiration Versus Chest Tube Drainage in First Episodes of Primary Spontaneous Pneumothorax: A French Multicenter, Prospective, Randomized Study (the EXPRED Study)/ T. Desmettre, F. Mauny, L.M.M. Joly, J.-B. Pretalli, D. Honnart, A.E.E. Dubart, C. Perrier, O. Tiffet, J.C. Dalphin, Besançon, France, p.A5581 3:15 CD206+CD14+ Macrophages, a Potential Biomarker for Diagnosis of Malignant Pleural Effusion/ X.-B. Pei, Beijing, China, p.A5582 3:30 Safety of Pleural Procedures Performed by Pulmonary and Critical Care Fellows: A Follow-Up Study/ A. Rothman, A. Shujaat, New York, NY, p.A5583 3:45 Trends and Outcomes in Surgical Management of Pleural Space Infections in the Era of TPA and DNase: Analysis Using Nationwide Data from 2005-2014/ E. Perez Power, M. Insel, C. Bime, Tucson, AZ, p.A5584 4:00 Theophylline and Systemic Corticosteroids in COPD: The TASCS Trial/ C.R. Jenkins, F.-Q. Wen, P.J. Barnes, B.R. Celli, N.-S. Zhong, J.-P. Zheng, A. Martin, N. Berend, Missenden Road, Australia, p.A7444 CLINICAL • TRANSLATIONAL MINI SYMPOSIUM C97 DON’T STOP BELIEVING: CLINICAL TRIALS IN PULMONARY VASCULAR MEDICINE 2:15 p.m. - 4:15 p.m. KBHCCD Room D162/D164 (Level 1) Chairing: M. Humbert, MD, PhD, Bicetre, France W. Seeger, MD, Giessen, Germany R.T. Zamanian, MD, Stanford, CA Oral Presentations 2:15 Impact of Initial Triple Combination Therapy on Long-Term Survival in Pulmonary Arterial Hypertension (PAH)/ A. Boucly, L. Savale, J.C. Weatherald, D. Montani, V. Cottin, C. Dauphin, F. Picard, D. Fard, X. Mignard, E.-M. Jutant, M. Jevnikar, X. Jaïs, G. Simonneau, M. Humbert, O. Sitbon, Le Kremlin Bicêtre, France, p.A5585 2:30 PVDOMICS: World Symposium Classification (WSPH) Group 1 vs Mixed WSPH Group 1 Disease: Splitters or Lumpers/ E. Horn, New York, NY, p.A5586 2:45 Risk Scores and Risk-Based Stratification of Clinical Worsening Events in Pulmonary Arterial Hypertension Participants Treated with Oral Treprostinil: FREEDOM-EV/ R.J. White, C. Jerjes-Sanchez, G.M. Bohns Meyer, T. Pulido, P. Sepulveda, K.Y. Wang, C.Q. Deng, R. Grover, V.F. Tapson, Rochester, NY, p.A5587 3:00 Clinical Trial of Metformin in Pulmonary Arterial Hypertension/ A. Hemnes, K. Niswender, K. Burke, R. Fan, R. Mallugari, J.H. Newman, M.E. Pugh, I.M. Robbins, C. Thompson, L. Wheeler, C. Yu, H. Zhu, J.D. West, E. Brittain, Nashville, TN, p.A5588 3:15 129Xenon MR Imaging and Spectroscopic Signatures to Differentiate Pulmonary Arterial Hypertension from Other Heart and Lung Disease/ E. Bier, Z. Wang, A. Swaminathan, J. Nouls, M. He, J. Mammarappallil, S. Luo, B. Driehuys, S. Rajagopal, Durham, NC, p.A5589 3:30 Decrease in Intraparenchymal Small Vessel Fraction in Exercise Pulmonary Arterial Hypertension/ F.N. Rahaghi, I. de La Bruere, I. Singh, P. Nardelli, C.E. Come, M. Faria Urbina, J. Leopold, A. Hunsaker, R. San José Estépar, R. San José Estépar, D.M. Systrom, A.B. Waxman, G.R. Washko, Boston, MA, p.A5590 3:45 Balloon Pulmonary Angioplasy (BPA) Versus Riociguat in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Systematic Review and Meta-Analysis/ W. Wang, L. Wen, Z. Song, W. Shi, K. Wang, W. Huang, Chongqing, China, p.A5591 4:00 Retinal Vascular Tortuosity, a New Feature of Systemic Manifestation of Pulmonary Arterial Hypertension/ N.P. Nickel, V. De Jesus Perez, A. Dubra, R.T. Zamanian, Stanford, CA, p.A5592 ATS 2019 • Dallas, TX 298 TUESDAY • MAY 21